Uthra Kumar is an accomplished healthcare and market access specialist with nearly two decades of experience in shaping access pathways, driving health system value, and advancing evidence-based decision-making. Her expertise spans market access strategy, health technology assessment (HTA), value proposition development, evidence generation, and innovative access models—enabling better outcomes for patients, providers, payers, and policymakers. Throughout her career, Uthra has demonstrated strong leadership in designing and executing impactful market access strategies across complex healthcare environments. As Director of Market Access at AstraZeneca, she led reimbursement and pricing efforts for the company’s full portfolio in key markets, managed strategic key account partnerships, and drove sales operations. She also pioneered innovative access models for oncology therapies, collaborating with internal teams and external stakeholders to expand patient access. Previously, as the Innovative Access Models Lead at Novartis, Uthra contributed to global value and access strategies for pipeline and launched products, strengthening frameworks for sustainable and patient-centric access. Her commitment to continuous learning is reflected in advanced certifications from globally renowned institutions, including Harvard University and SDA Bocconi, enhancing her expertise in HTA, policy, and value-based healthcare. Passionate, analytical, and impact-driven, Uthra Kumar is dedicated to transforming health systems and enabling equitable access to innovative therapies through strategic insights, collaborative leadership, and a deep understanding of the healthcare landscape.